Name: Erik J. BehringerUSA

Academic degree:

Ph.D.

Affiliation and title:

Basic Sciences, Pharmacology Division, School of Medicine, LOMA LINDA UNIVERSITY

Research expertise:

Aging on the cardiovascular and nervous systems, Brain microcirculation, Alzheimer’s disease

Name: Tarun SahniIndia

* President 2024, Hyperbaric Society of India

Academic degree:

M.D. MBBS, DMM

Affiliation and title:

Head of Hyperbaric Medicine & Sr. Consultant Internal Medicine, Indraprastha Apollo Hospital, New Delhi

Research expertise:

Hyperbaric oxygen therapy, Internal Medicine

Name: Mahito KawashimaJapan

* President 2024, APUHMS

Academic degree:

M.D., Ph.D.

Affiliation and title:

Executive Director, Kawashima Orthopedic Hospital; Clinical Professor, Faculty of Medicine, Oita University; President of APUHMS

Research expertise:

Hyperbaric oxygen therapy, Osteonecrosis, Rheumatoid arthritis

Name: Kazuyoshi YagishitaJapan

* Representative director 2024, JSHUM

Academic degree:

M.D., Ph.D.

Affiliation and title:

Director, Hyperbaric Medical Center, Tokyo Medical and Dental University (TMDU)

Research expertise:

Hyperbaric oxygen therapy, sports orthopedics, knee surgery

Name: Bernard Cheung (張文勇)Hong Kong

Academic degree:

MB BChir, PhD, FRCP, FRCPE, FHKCP, FHKAM(Medicine), FBPhS, FBHS

Affiliation and title:

Honorary Clinical Professor, University of Hong Kong

Research expertise:

Clinical pharmacology, cardiovascular disease

Name: Ronglih Liao (廖容麗)USA

Academic degree:

Ph.D.

Affiliation and title:

Co-Director of Stanford Amyloid Center; Professor, School of Medicine, Stanford University,

Research expertise:

Amyloid light chain (AL) cardiomyopathy, stem cell biology

Name: Xi-Yong Yu (余細勇)China

* Vice President 2024, Chinese Pharmacological Society

Academic degree:

Ph.D.

Affiliation and title:

President, School of Pharmaceutical Science, Guangzhou Medical University;

Research expertise:

Molecular clinical pharmacology, epigenetic pharmacology, molecular pharmaceutical biology

Name: Alex F. Chen (陳豐原)ChinaUSA

* Editor-in-Chief, Frontiers in Integrated and Regulatory Pharmacology

Academic degree:

MD, PhD, FAHA

Affiliation and title:

Director, Institute for Cardiovascular Development and Regenerative Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Research expertise:

Vascular injury and repair, vascular endothelial cell dysfunction in hypertension and diabetes

Name: Jin-Cai Luo (羅金才)China

* 副主任委員，血栓與止血專業委員會，中國生理學會

Academic degree:

Ph.D.

Affiliation and title:

Professor, Institute of Molecular Medicine, College of Future Technology, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University

Research expertise:

Vascular Biology, lymphangiogenesis, vascular remodeling

Name: Si-Feng Chen (陳思鋒)China

* Vice President 2024, Chinese Association for Physiological Science

Academic degree:

Ph.D.

Affiliation and title:

Professor, Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Fudan University

Research expertise:

Stem cell research, Pathogenesis of intima disease, diabetes, acute lung injury

Name: Po-Hsun HuangTaiwan

* President 2024, Taiwan society of lipids & atherosclerosis

Academic degree:

M.D., Ph.D.

Affiliation and title:

Professor, Institute of Clinical Medicine, National Yang-Ming Chiao Tung University; Director, Department of Critical Care Medicine, Taipei Veterans General Hospital

Research expertise:

Invasive Cardiology, Basic research on vascular biology

Name: Yi-Sheng ChanTaiwan

* President 2024, Taiwan orthopaedic association (TOA)

Academic degree:

M.D., Ph.D.

Affiliation and title:

Director, Department of Orthopedics Surgery, Chang Gung Memorial Hospital LinKou Branch; Professor, Department of Orthopedics, Chang Gung Memorial University

Research expertise:

Hyperbaric oxygen therapy, reconstruction and recovery after sports injuries